Standard BioTools's total assets for Q3 2024 were $681.54M, a decrease of -3.84% from the previous quarter. LAB total liabilities were $192.21M for the fiscal quarter, a -3.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.